Advanced Cell Technology, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 72   

Articles published

ACTC 0.0637 +0.0009 (1.43%)
price chart
Advanced Cell Technology: A Key Patent Critique (Part II)
The focus on credibility is very positive for the future of the company and as a potential investor, I applaud the effort. It truly is an inflection point in the management of the company, as I stated in my prior article, Advanced Cell Technology: A ...
Related articles »  
BioTime, Inc. (BTX) news: BioTime Joins Advanced Cell Technology In The AMD ...
"Advanced Cell Technology: A Balanced Perspective Or Risk And Reward" - This article summarized the legacy issues involving Advanced Cell Technology and future potential of the company. Prior management left the company at the end of 2013, and the ...
Advanced Cell Technology: A Key Patent Critique
Advanced Cell Technology's patent claims vs. the scientific method used in their AMD trial appear contradictory. This is a follow up to my prior article: ... Advanced Cell Technology (OTCQB:ACTC) filed their 10-K and had a conference call to discuss ...
Advanced Cell Technology On The Doorstep
Advanced Cell Technology (OTCQB:ACTC) filed their annual 10-K report on Wednesday, after some delay. This massive ... The document provides critical information on the company's finances and the status of their various programs. ACT also hosted a ...
Small Cap Alert - MENTOR CAPITAL, INC (OTCMKTS:MNTR), Advanced Cell ...
Manhattan, NY- April 17, 2014 - (Techsonian) �MENTOR CAPITAL, INC (OTCMKTS:MNTR) recently declared that its flagship portfolio company, Bhang Chocolate Company, Inc., will be premiering its newest line of High CBD products at this weekend's High ...
Advanced Cell Technology to Present at Regenenerative Medicine Investor Day ...
Advanced Cell Technology, Inc. is a Marlborough, Mass.-based biotechnology company focused on the development and commercialization of human embryonic stem cell (hESC) and adult stem cell technology.
Related articles »  
Advanced Cell Technology to Host Conference Call to Provide a Corporate Update
Advanced Cell Technology, Inc. ("ACT"; OTCBB:ACTC), a leader in the field of regenerative medicine, announced today that it filed its annual report on Form 10-K for the year ended December 31, 2013.
Related articles »  
Trader's Buzzers � MyEcheck Inc (OTCMKTS:MYEC), Advanced Cell ...
Advanced Cell Technology, Inc. (OTCMKTS:ACTC), a leader in the field of regenerative medicine, and its collaborators reported today that it has discovered a new method to generate a potent and replenishable population of mesenchymal stem cells from ...
Stocks in the Spotlight: Advanced Cell Technology, Inc. (OTCMKTS:ACTC ...
New York, NY- April 09, 2014 - (Techsonian) - Advanced Cell Technology, Inc. (ACTC), a leader in the field of regenerative medicine, and its collaborators reported today that it has discovered a new method to generate a potent and replenishable ...
Related articles »  
Penny Stocks on Trader's Radar - Advanced Cell Technology, Inc.( ACTC ...
Advanced Cell Technology, Inc. (OTCMKTS:ACTC) lost volume of 3.28M shares and the average volume of the stock remained 13.17M shares.